A comparative study to evaluate the efficacy of Dashmulyadi Kwatha and Shringyadi Churna in the management of Tamaka Shwasa with special reference to Bronchial Asthma
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- Complete Remission
研究概览
简要总结
A comparative clinical study will be undertaken to evaluate the efficacy of Dashmulyadi Kwatha and Shringyadi Churna in the management of Tamaka Shwasa w.s.r. Bronchial Asthma. In Group I Dashmulyadi kwatha will be given for total duration of 60 days and in Group II Shringyadi Churna will be given for total duration of 60 days. Clinical Assessment of the patients will be done on the basis of subjective and objective parameters at .15th, 30th , 45th and 60th day of the trial and Follow up will be done at 30 th day and 60th day after the completion of the trial. Inference will be made after application of the suitable statistical tests.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patient having classical features of Tamaka Shwasa.
- •Presence of symptoms of airflow obstruction 2 or more of cough, wheezing, dyspnoea.
- •Airflow obstruction is atleast partially reversible.
- •Oxygen saturation greater than 90 percent Cases included from intermittent mildly persistent to moderate persistent asthma.
- •PEFR more than 60 percent of the predicted value.
排除标准
- •PEFR less than equals to 60 percent of the predicted value orless than 100 litre per min equals to Severe Exacerbation(Status Asthmaticus).
- •Blood Oxygen saturation less than 90 percent Asadhya Lakshanas of Tamaka Shwasa.
- •The patient with history of Tuberculosis, COPD, Emphysema, Chronic airway obstruction, Status Asthmaticus, Cardiac asthma, CAD.
- •History of Endocrine disorders like diabetes mellitus, thyroidism.
- •known case of Hypertension Other complicated respiratory diseases having any organic lesion such as tumor or any anatomical defect in airway.
- •If the patient exhibits short seasonal changes of less than 4 weeks duration.
- •Any other physical and surgically ill patient will be excluded.
- •Severe exacerbation inspite of medication.
结局指标
主要结局
Complete Remission
时间窗: 15th day, 30th day, 45th day, 60th day
Markedly Improved
时间窗: 15th day, 30th day, 45th day, 60th day
Moderately Improved
时间窗: 15th day, 30th day, 45th day, 60th day
Mildly Improved
时间窗: 15th day, 30th day, 45th day, 60th day
Unchanged
时间窗: 15th day, 30th day, 45th day, 60th day
次要结局
- Exacerbations in signs and symptoms(30th day, 60 th day after the completion of trial.)
研究者
Kimmi Seth
Motherhood Ayurveda Medical College